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Research Article
An essential role for α4A-tubulin in platelet biogenesis
Catherine Strassel1, Maria M Magiera2,3 , Arnaud Dupuis1 , Morgane Batzenschlager1 , Agnès Hovasse4,
Irina Pleines5,6, Paul Gue´guen7, Anita Eckly1, Sylvie Moog1, Le´a Mallo1, Quentin Kimmerlin1, Ste´phane Chappaz5,6,
Jean-Marc Strub4, Natarajan Kathiresan2,3, Henri de la Salle1, Alain Van Dorsselaer4, Claude Ferec7, Jean-Yves Py8 ,
Christian Gachet1, Christine Schaeffer-Reiss4, Benjamin T Kile5,6, Carsten Janke2,3 , François Lanza1
During platelet biogenesis, microtubules (MTs) are arranged into
submembranous structures (the marginal band) that encircle the
cell in a single plane. This unique MT array has no equivalent in
any other mammalian cell, and the mechanisms responsible for
this particular mode of assembly are not fully understood. One
possibility is that platelet MTs are composed of a particular set of
tubulin isotypes that carry speciﬁc posttranslational modiﬁca-
tions. Although β1-tubulin is known to be essential, no equivalent
roles of α-tubulin isotypes in platelet formation or function have
so far been reported. Here, we identify α4A-tubulin as a pre-
dominant α-tubulin isotype in platelets. Similar to β1-tubulin,
α4A-tubulin expression is up-regulated during the late stages of
megakaryocyte differentiation. Missense mutations in the α4A-
tubulin gene cause macrothrombocytopenia in mice and humans.
Defects in α4A-tubulin lead to changes in tubulin tyrosination
status of the platelet tubulin pool. Ultrastructural defects include
reduced numbers and misarranged MT coils in the platelet
marginal band. We further observed defects in megakaryocyte
maturation and proplatelet formation in Tuba4a-mutant mice.
We have, thus, discovered an α-tubulin isotype with speciﬁc and
essential roles in platelet biogenesis.
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Introduction
Blood platelets are produced by megakaryocytes (MKs) in the bone
marrow and are essential to arrest bleeding in mammals. In the
ﬁnal stages of platelet biogenesis, microtubules (MTs) are arranged
into a submembranous structure, the marginal band, which en-
circles the platelets in a single plane. This circular scaffold is es-
sential for maintaining the ﬂattened lenticular shape of platelets
(1, 2) and has no equivalent in any other mammalian cell. The bi-
ological importance of the marginal band has been demonstrated
by the observation that MT depolymerization with colchicine, or by
cold exposure, induces a transition of platelets to a spherical shape
and alters platelet function (3). In addition, decreased platelet
counts and enlarged spheroid platelets have been observed in
patients and animals with genetic deﬁciencies in the platelet-
speciﬁc β1-tubulin isotype (4, 5).
MTs in platelets undergo dramatic bending when forming the
marginal band; however, the underlying mechanisms remain to be
elucidated. When MKs are differentiated in culture, MT coiling in the
extending pseudopods occurs during proplatelet formation.
Pseudopods show platelet-sized swellings at their extremities,
which will later bud off as platelets (6). The dynamics of MT growth
and sliding in proplatelets depend on the dynein/dynactin motor
complex (7, 8), but it is unclear how MT ring formation and main-
tenance is regulated.
The particular mode of MT assembly in platelets suggests
that tubulin building blocks might have unique biochemical
and structural properties. In humans, nine α-tubulin and nine
β-tubulin genes encode a variety of tubulin isotypes (9). Within the
α- and the β-tubulin families, isotypes show more than 90% amino
acid identity, with the notable exception of β1-tubulin. The gene
encoding this particular isotype, TUBB1, was initially cloned from a
bone marrow cDNA library (10) and subsequently demonstrated to
be speciﬁcally expressed in MKs and platelets (11). It is now clear
that incorporation of β1-tubulin into platelet MTs is critical for the
formation of the marginal band and, therefore, for platelet for-
mation and function. It is one of the most striking examples of a
functional specialized, unique, and essential role for a tubulin
isotype. Other isotypes have also been found to be speciﬁcally in-
corporated into selected MTs, such as β3-tubulin in neurons (12, 13),
or β4-tubulin in cilia and ﬂagella (14, 15).
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The mechanical properties of MTs are thought to be pre-
dominantly governed by lattice interactions (16). As such, it might
be expected that they could be altered by the incorporation of a
particular set of tubulin isotypes into the lattice (17). Although the
essential role of β1-tubulin for platelet MTs has so far only been
determined by genetic approaches, it is highly likely that its in-
corporation changes the mechanical and dynamic properties of
platelet MTs.
Strikingly, nothing is known about the role of α-tubulin isotypes
in platelets and MKs. The reason for the lack of insight into the
α-tubulin repertoire is most likely related to the fact that so far, no
reliable methods are available to quantitatively characterize the
composition of the tubulin isotype pool, and that DNA and peptide
sequences of α-tubulin isotypes are even more similar among
each other than those of β-tubulins, making quantitative analyses
challenging. To detect isotypes that could be important for plate-
let biogenesis, we investigated the composition of the tubulin
isotype pool of platelet MTs with a speciﬁc focus on the yet
unexplored α-tubulin isotypes. Using quantitative proteomics, we
found a strong enrichment of α4A-tubulin in platelets. The ex-
pression of α4A-tubulin is up-regulated during the late stages of
MK differentiation, and we found an enrichment of α4A-tubulin in
platelets. This is reminiscent of the proﬁle of β1-tubulin ex-
pression, suggesting that α4A-tubulin plays essential roles in
platelets.
Indeed, mice carrying a missense mutation in the Tuba4a gene,
and a patient with a monoallelic double missense mutation in the
TUBA4A gene displayed macrothrombocytopenia and structural
abnormalities in the marginal band of platelets. In addition, de-
fective MKmaturation and proplatelet formation were observed in
the mutant mouse model. The fact that these phenotypes are
highly similar to the β1-tubulin–mutant phenotypes implies a
similarly essential role of α4A-tubulin in late stages of platelet
biogenesis.
Materials and Methods
Mice
Plt68 mice carrying a mutant Tuba4a allele were generated. Male
BALB/cmice were injected i.p. with 85mg/kg N-ethyl-N-nitrosourea
(ENU) weekly for 3 wk and rested for 12 wk before mating with
untreated BALB/c females to produce ﬁrst-generation progeny.
Blood was taken at 7 wk of age, and animals exhibiting aberrant
platelet counts and morphology were test-mated to determine
heritability of the phenotype. Conﬁrmed mutant strains were
backcrossed for 10 generations to the BALB/c background to breed
out irrelevant ENU-induced mutations.
Reagents
Polyclonal antisera against mouse β1-tubulin (pAb5274) and
human/mouse α4A-tubulin (pAb7620 and pAb7621) were generated
by immunizing against peptides 451-VLEEDEEVTEEAEMEPEDKGH-471
and 76-DEIRNGPYR-84, respectively.
2D-gel electrophoresis and liquid chromatography-mass
spectrometry/mass spectrometry analysis of platelet tubulin
2D-gel electrophoresis was performed according to Magnin-Robert
et al (18). Spots of interest were extruded and submitted to in-gel
digestion (19) and then processed for mass spectrometry as de-
scribed in the Experimental Procedures section of the Supple-
mentary Information.
LC-Single Reaction Monitoring (SRM) quantiﬁcation of α-tubulin
isotypes
For LC-SRM assay, proteotypic peptide (EIIDPVLDR and DVNVAIAAIK)
signatures of α4A- and α8-tubulin, respectively, and one peptide
(NLDIERPTYTNLNR) common to all α-tubulins were selected. The
samples were processed for LC-SRM quantiﬁcation as described
in the Experimental Procedures section of the Supplementary
Information.
MK culture
Human CD34+ cells were cultured as described previously (20).
Mouse bone marrow Lin− cells were cultured as described pre-
viously (21). Additional information is provided in the Experimental
Procedures section of the Supplementary Information.
Proplatelet formation in bone marrow explants
Marrows from femurs were ﬂushed and cut in transverse sections of
0.5 mm. MKs were observed after 6-h incubation at 37°C, at the
periphery of the tissue as described previously (22).
Immunoﬂuorescence microscopy
Blood was obtained from anesthetized mice and platelets were
washed according to Cazenave et al (23). Platelets were ﬁxed in 4%
PFA, cytospun onto poly-L-lysine–coated slides and processed for
immunoﬂuorescence microscopy as described in the Experimental
Procedures section of the Supplementary Information.
Western blotting
Proteins, corresponding to 107 platelets or 300 ng of puriﬁed tu-
bulins were separated on 4%–15% or 10% SDS gels for separation of
α and β-tubulin (24), blotted onto polyvinylidene diﬂuoride mem-
branes, and processed for Western blotting as described in the
Experimental Procedures section of the Supplementary Information.
Screening and gene sequencing of blood donors
Blood donors with a platelet count below 150 G/L were selected,
DNA extracted from buccal swabs, and 17 selected genes suspected
to be implicated in thrombocytopenia, including TUBA4A, were
ampliﬁed by PCR using amplimers encompassing the coding se-
quences, intron–exon junctions, and 59 and 39 UTR (ABC study
approved by ANSM-French agency for the safety of drugs and health
products registered under identiﬁcation number RCB: 2014-A00002-
45; informed consent was obtained for each individual).
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Statistical analyses
Results were expressed as the mean (±SEM) and statistical com-
parisons were performed using an unpaired, two-tailed t test or a
one-way ANOVA followed by the Bonferroni post hoc test.
Results
Analysis of the α-tubulin isotype repertoire in circulating
platelets and during megakaryopoiesis
Previous studies in mouse have reported an up-regulation of β1-
tubulin expression during megakaryopoiesis and estimated that
this isotype represented a large proportion of total β-tubulin pool
in circulating platelets (5). In contrast, a quantiﬁcation of α-tubulin
isotypes in platelets and MKs has so far not been performed. In a
ﬁrst series of experiments, we established the full repertoire of
α-isotypes by nanoLC-MS/MS analysis. Tubulin puriﬁed from hu-
man platelets was separated by 2D electrophoresis as described in
Adessi et al (25), and the main Coomassie-stained spots (Fig 1A)
were dissected and submitted to nanoLC-MS/MS analysis. We
identiﬁed α1C-, α3C/D-, α3E-, α4A-, and α8-tubulin isotypes. This
represents virtually all known α-isotypes, bearing in mind that
highly similar isotype groups are not distinguishable with this
method.
To determine the dynamics of α-tubulin isotype expression, we
quantiﬁed mRNA levels during MK differentiation of human CD34+
cells (20). Tubulin isotypes within highly homologous subgroups
(TUBA1 and TUBA3) were analyzed together using cross-reactive
primers. The expression of isotypes from the TUBA1 group was
already detected at D0, increased early during differentiation (D4),
and then remained stable until full maturation (D12; Fig 1B). In
contrast, expression of TUBA4A and TUBA8 transcripts progressively
increased from D4 until D12, a stage just preceding proplatelet
extension andmarginal band formation. TUBA3 transcripts were not
detected throughout differentiation (data not shown). Strikingly,
the expression proﬁle of TUBA4A and TUBA8 mirrors TUBB1, thus
providing a further indication for the potential functional com-
plementarity of these isotypes.
To determine the prevalence of α4A- and α8-tubulin isotypes at
the protein level, we submitted tubulin puriﬁed from human
platelets to a quantitation assay using a targeted mass spectrometry
approach called SRM with quantiﬁed stable isotope-labeled pep-
tides (AQUA peptides) as internal standards (26). Using speciﬁc
signatures from α4A- and α8-peptides, and normalizing them to a
common peptide shared by all α-tubulin isotypes, LC-SRM analysis
showed a sizable fraction of α4A-tubulin (29 ± 6%, n = 6), but only low
levels of α8-tubulin (2.0 ± 1.4%, n = 6) in the platelet tubulin pool (Fig
1C). This is striking as so far α4A-tubulin had been reported to be
expressed inmany tissues, however, generally at low transcript levels
compared with other α-tubulins (27).
Using an α4A-tubulin–speciﬁc antibody that we had raised
against a sequence unique to α4A-tubulin (76-DEIRNGPYR-84,
pAb7621), we compared the level of α4A-tubulin in MTs puriﬁed
from platelets, brain tissue, and HeLa cells. Western blot analysis
revealed that the levels of α4A-tubulin in platelet MTs are well
above those in HeLa cells and also higher than those in brain (Fig
1D). This conﬁrmed that α4A-tubulin is particularly enriched in
platelet MTs and indicates that it might play a particular role in the
formation of the marginal band.
A missense mutation in Tuba4a gene causes
macrothrombocytopenia and abnormal marginal band formation
in mice
To establish the role of α4A-tubulin in the formation of themarginal
band, we analyzed a mouse strain (named Plt68) that we had
identiﬁed from an ENU mutagenesis screen. Plt68 mice exhibited
decreased platelet counts (a 21% reduction compared with wild-
type mice, 943 × 103/μl versus 1,199 × 103/μl; Fig 2A). In addition,
platelets from these mice exhibited an increased size with mean
platelet volumes (MPV) representing 143% of those in wild-type mice
(7.0 fL versus 4.9 fL; Fig 2B).
Exome sequencing of two Plt68 animals, followed by genotyping of
candidate mutations in siblings and offspring revealed that the Plt68
phenotype correlated with inheritance of a point mutation in the
Tuba4a gene. The mutation is predicted to encode a valine-to-
glutamate substitution at position 260 ofα4A-tubulin (P68366; Fig 2C).
We next examined the ultrastructure of Tuba4aV260E/V260E plate-
lets by scanning and transmission electron microscopy. This
analysis conﬁrmed the increased size of the platelets and revealed
the loss of their typical ﬂat, discoid shape (Fig 2D). Close-up views
of transmission electron microscopy (TEM) cross sections (Fig 2E)
revealed a reduction in the number of MT coils in themarginal band
of Tuba4aV260E/V260E platelets (average 5 ± 1.0 coils/platelet com-
pared with 11 ± 0.6 coils in the wild-type). Similar defects have been
described for mice lacking β1-tubulin (5) (Fig S1) or patients har-
boringmutations in the TUBB1 gene (4). Consequently, these results
imply that α4A-tubulin has, similar to β1-tubulin, an essential role
in the formation of the marginal band during platelet biogenesis.
Naturally occurring mutations of TUBA4A in a human individual
with moderate macrothrombocytopenia
To determine whether these observations in mice are relevant to
humans, we screened for TUBA4A mutations in individuals pre-
senting with low platelet counts. Blood donors with subthreshold
platelet counts (<150 × 103/μl) were subjected to targeted se-
quencing of genes possibly implicated in thrombocytopenia. One
individual was identiﬁed with a monoallelic c.541G>A and c.547G>C
double substitution in TUBA4A predicting p.Val181Met and p.
Glu183Gln mutations in α4A-tubulin (Fig 3A). These mutations were
conﬁrmed by Sanger sequencing. Database searches indicated
that they correspond to very rare variants, with frequencies of 8e-5
and 2e-5 for c.541G>A (rs757373635) and c.547G>C (rs775821469),
respectively.
Platelet counts recorded for the patient between 2008 and 2017
(n = 26) ranged between 137 and 164 × 103/μl, but MPVs were not
available. Follow-up evaluation of the blood parameters conﬁrmed
a platelet count at the lower limit of normal values (158 × 103/μl),
considering normal ranges for platelet counts of 172–398 × 103/μl in
a French adult male population (16–59 y: n = 17,646) (28) and
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Figure 1. Expression of α-tubulin isotypes in platelets and during megakaryopoiesis.
(A) 2D-gel electrophoresis of tubulins puriﬁed from human platelets and list of identiﬁed α-isotypes. The isotypes were identiﬁed by LC-MS/MS analysis of the color-
marked spots (blue, red, and double labelling correspond to spots containing α-, β-, and αβ isotypes, respectively). (B) Evolution of α1-, α4A-, α8-, and β1-tubulin
transcripts at different stages of MK differentiation. RT-PCR ampliﬁcation of RNA isolated from MKs differentiated from human CD34+ progenitor cells at days 0 to 12 of
culture. Bands were quantiﬁed on gels and intensity normalized to 18S (mean ± SEM, n = 3). (C) SRM-MS quantiﬁcation of the α4A- and α8-tubulin isotypes in tubulin
puriﬁed from human platelets. The content normalized to the total α-tubulin content was calculated as described in the methods from six separate tubulin preparations
with analyses performed in triplicate. (D) Western blot analysis of α4A-tubulin levels in tubulin puriﬁed from platelets, the brain, and HeLa cells. (Upper panel)
Quantiﬁcation of α4A-tubulin levels in HeLa and brain tubulin relative to platelet tubulin after normalization to the total α-tubulin content. (Lower panel) Representative
blot where equivalent amounts of puriﬁed tubulin (300 ng) were separated on a 10% gel and probed using pAb7621 polyclonal Ab speciﬁc for α4A-tubulin and DM1amouse
mAb recognizing all the α-tubulin isotypes.
α4A-tubulin in platelet formation Strassel et al. https://doi.org/10.26508/lsa.201900309 vol 2 | no 1 | e201900309 4 of 13
α4A-tubulin in platelet formation Strassel et al. https://doi.org/10.26508/lsa.201900309 vol 2 | no 1 | e201900309 5 of 13
revealed an increased mean platelet volume (12.9 fL; normal range:
7.8–10.8 fL) (28). Electron microscopy analyses of the patient’s
platelets revealed similar defects to those in Tuba4aV260E/V260Emice
with a loss of the typical ﬂat, discoid shape (Fig 3B and C). TEM cross
sections did not, however, reveal a decrease in the number of MT
per platelet (10.9 ± 0.4 for patient versus 11.4 ± 0.5 for control), but
rather a profound disorganization of the marginal band, featuring
loosely assembled MTs (Fig 3C). Together with the results of our
mouse model, these ﬁndings strongly support an evolutionarily
conserved key role of α4A-tubulin in platelet biogenesis.
Effect of Tuba4a mutations on α4A-tubulin expression and on
tyrosination of the α-tubulin pool
We next evaluated the consequences of Tuba4aV260E and TUBA4A
mutations on the expression of α4A-tubulin by Western blotting
using isotype-speciﬁc antibodies. Although we detected a speciﬁc
55-kD protein band in platelet extracts from wild-type mice (Fig 4A)
and normal human individuals (Fig 4B), this band was not detected
in platelet extracts from Tuba4aV260E/V260E mice, and the signal was
decreased in extracts from the patient. qRT-PCR performed in
cultured MK did not reveal a decrease in Tuba4a transcript levels in
Tuba4aV260E mice and additionally conﬁrmed the increase of
Tuba4a during differentiation (Fig S2), as in human cultured MK.
Consistent with this, a dramatic reduction in labelling of the
marginal band using the α4A-tubulin antibodies was observed in
mutant platelets relative to those from wild-type mice (Fig 4C) or
human control individuals (Fig 4D). Other α-tubulin isotypes were
present at relatively normal levels in extracts from Tuba4aV260E/V260E
mice and the patient, as seen with the pan-α-tubulin DM1A antibody
(29). The fact that overall α-tubulin levels are unaltered in the ab-
sence of TubA4A is most likely related to the adaptation of the
expression levels of the remaining α-tubulin isotypes (30, 31). We also
determined the expression of β1-tubulin and found no obvious
changes.
The nearly complete absence of α4A-tubulin in Tuba4aV260E/V260E
mice could be caused by the misfolding of the protein and sub-
sequent degradation. We thus performed 3D modelling of
Tuba4aV260E/V260E, which shows that the V260E mutation is situated
within the core region of the protein (Fig S3). Thus, the substitution
of hydrophobic valine by a charged glutamate might destabilize the
entire core region, thereby affecting the conserved tubulin fold,
leading to misfolded tubulin being degraded (32).
Compared with other α-tubulins, α4A-tubulin shows a rather
high level of sequence conservation. However, an outstanding
feature of α4A-tubulin is the lack of a C-terminal tyrosine residue,
which is present on all other α-tubulin isotypes (or substituted by a
functionally similar phenylalanine). Tyrosinated α-tubulin isotypes
can undergo enzymatic posttranslational detyrosination and
retyrosination, and strict regulation of this “tyrosination cycle” is
essential for a variety of MT functions (reviewed in reference 33). A
strong expression of α4A-tubulin might signiﬁcantly increase the
initial levels of detyrosinated tubulin in MKs and platelets, thus
affecting tyrosination-dependent MT functions. We examined the
levels of tyrosinated and detyrosinated tubulin in platelets of
Tuba4aV260E/V260E mice and from the patient. Western blotting
analysis with an antibody directed against tyrosinated α-tubulin
(Tyr-tubulin) showed stronger labelling in both cases relative to
controls which implies a signiﬁcant increase in tyrosination of the
α-tubulin pool (Fig 4A and B). Conversely, the level of detyrosinated
tubulin was decreased in Tuba4aV260E/V260E platelets, but less so in
the patient’s platelets. It thus appears that the high proportion of
detyrosinated α-tubulin in wild-type platelets might primarily be
the result of the strong expression of α4A-tubulin in platelets, and
absence or reduction of this isotype strongly affects the levels
of this otherwise posttranslationally controlled modiﬁcation of
tubulin.
Acetylation is another tubulin posttranslational modiﬁcation
present in native resting platelets (34). It has been proposed to play
a regulatory role during platelet activation and shape change (35),
whereas its role in platelet biogenesis is still debated (36, 37). We
veriﬁed the levels of tubulin acetylation between wild-type and
Tuba4aV260E/V260E platelets but could not detect signiﬁcant differ-
ences (Fig S4). This suggests that tubulin acetylation is not involved
in the defects observed in Tuba4aV260E/V260E mice.
α4A-tubulin–deﬁcient MKs have a reduced capacity to extend
proplatelets
To determine the impact of α4A-tubulin deﬁciency on the process
of platelet formation, we analyzed each step ofmegakaryopoiesis in
Tuba4aV260E/V260E mice. The bone marrow showed a normal cellular
distribution of morphologically distinguishable MKs (stages I–III; Fig
5A), and no ultrastructural defects were noted in the less mature
MKs (stages I–II). In contrast, a notable proportion (~30%) of stage III
MKs exhibited an abnormal structure with a more compact de-
marcation membrane system (Fig 5B). When we examined the
capacity of bone marrow–derived MKs to extend proplatelets by
real-time analysis of fresh bone marrow explants (22), we noted a
profound defect in Tuba4aV260E/V260E MKs: MKs from these mice
were unable to extend well-developed proplatelets, which are
typically observed in wild-type MKs at this stage (Fig 6A). Most of the
Tuba4aV260E/V260E MKs retained a spherical shape during the 360-
min course of observation, and only a small proportion extended a
few thick protrusions. This phenotype is characteristic for defective
proplatelet formation.
Figure 2. An ENU-induced mutation of Tuba4a causes macrothrombocytopenia and abnormal marginal band formation.
(A) Decreased platelet counts in Plt68 mice. The number of circulating platelets in wild-type and Plt68mice is represented for each individual mouse (1,199 ± 183 versus 943
± 207 × 103 platelets/μl, respectively; mean ± SEM n = 21 wild type and n = 33 Plt68; ***P = 0.0026; t test). (B) Increased platelet volume in Plt68mice. Themean platelet volume
in wild-type and Plt68 mice is represented for each individual mouse (4.9 ± 0.34 versus 7.0 ± 0.17 fL respectively; mean ± SEM n = 21 and n = 33; ***P < 0.0001; t test). (C)
Schematic representation of the V260E mutation: A mutation was identiﬁed in the gene encoding α4A-tubulin (Tuba4a) in the Plt68 strain resulting in a Val-to-Glu
transition at position 260 of the protein (P68366). (D) Representative scanning electron microscopy images of wild-type and Tuba4aV260E/V260E platelets. (E) Representative
transmission electron microscopy images of wild-type and Tuba4aV260E/V260E platelet suspensions (upper panels) and close-up views of individual platelets in cross
section (lower panels).
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We next examined the impact of α4A-tubulin deﬁciency in MKs
differentiated from Lin− bone marrow progenitors in vitro (21).
Strikingly, a defect similar to that observed in explants was
observed after 4 d in culture, a time point at which proplatelet
formation takes place (Fig 6B). Almost 40% of Tuba4aV260E/V260E
MKs extended only few thick protrusions, indicative of poorly
Figure 3. Naturally occurring mutations of TUBA4A in an individual with mild macrothrombocytopenia.
(A) A double substitution was identiﬁed in TUBA4A in the patient, resulting in p.Val181Met and p.Glu183Gln changes in α4A-tubulin. (B) Representative scanning electron
microscopy images of control and patient’s platelets. (C) Representative transmission electron microscopy images of control and patient’s platelet suspensions (upper
panels) and close-up views of individual platelets in cross section (lower panels).
Figure 4. Effect of Tuba4a mutations on α4A-tubulin
expression and on tyrosination of the α-tubulin pool.
(A) α4A-tubulin is not detected in platelets from
Tuba4aV260E/V260E mice and the α-tubulin pool is
hypertyrosinated. Platelet lysates from wild-type and
Tuba4aV260E/V260Emice were separated by SDS-PAGE and
probed with pAb7621 against α4A-tubulin, DM1a
recognizing all the α-tubulin isotypes, pAb5274 against
β1-tubulin, 1.A2 against tyrosinated α-tubulin, or 1D5
against detyrosinated α-tubulin. Blots were also probed
for GAPDH as a loading control. Representative of four
separate experiments. (B) α4A-tubulin is decreased in
platelets from the patient and the α-tubulin pool is
hypertyrosinated. Platelet lysates from a control
individual and the patient were processed as in (A). (C,
D) Decreased α4A-tubulin labelling in the marginal
band of platelets from Tuba4aV260E/V260E mice (C) and the
patient (D). Platelets were ﬁxed in PFA-Triton X-100,
captured on poly-L lysine–coated slides, incubated with
pAb7620 or pAb7621 against α4A-tubulin and revealed
with GAR-Alexa 488.
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developed proplatelets, whereas this phenotype was observed in
less than 10% of wild-type MKs. This conﬁrmed the notion that in
the absence of α4A-tubulin, the early differentiation program of
MKs is maintained, whereas the later stages of MK maturation and
proplatelet formation are affected. The functional importance of
α4A-tubulin in later stages of MK maturation coincides with the
increased expression of TUBA4A in these developmental stages
(Fig 1B).
Discussion
Our knowledge of the distribution and function of tubulin isotypes
is very rudimentary. In platelets, β1-tubulin was found to be the
major β-tubulin isotype, and its expression was, for a long time,
thought to be restricted to the MK lineage (11). Recently, TUBB1 has
also been detected in the thyroid, where it is important for the
development of the thyroid gland (38). Studies of β1-tubulin–
deﬁcient mice, as well as the identiﬁcation of patients carrying
mutation in the TUBB1 gene provided strong support for its
functional importance in platelets (4, 5). In contrast, nothing was so
far known about the role of speciﬁc α-tubulin isotypes, which are
more difﬁcult to quantify because of the extraordinary conserva-
tion of their peptide sequences. We overcame this obstacle by
developing a quantitative mass spectrometry assay, revealing a
strong α4A-tubulin enrichment in platelets. So far, TUBA4A had
been found most abundantly only in the heart and muscle (27). Our
data thus reveal a unique isotype composition of platelet tubulin,
with high proportions of α4A- and β1-tubulin that could account for
the unique structural and dynamic properties of MTs in their
marginal band. However, in contrast to β1-tubulin, which shows
a strong sequence divergence from all other β-tubulin isotypes,
the amino acid sequence of α4A-tubulin is similar to most other
α-tubulin isotypes. It is, thus, puzzling why its absence cannot be
compensated by other α-tubulins.
There is, however, one unique feature distinguishing α4A-tubulin
from all other α-tubulin isotypes: it does not encode the ultimate
C-terminal tyrosine residue. This implies that the prominent ex-
pression of α4A-tubulin in platelets shifts the tubulin pool toward
detyrosinated α-tubulin, which we indeed demonstrate in α4A-
tubulin–deﬁcient platelets in both, the mutant mouse and the
patient. Perturbing the tyrosination/detyrosination balance can
have dramatic impacts: mice lacking tubulin tyrosine ligase show
strong accumulation of detyrosinated α-tubulin and die post-
natally. Neurons from these mice show uncontrolled and pre-
mature neurite outgrowth due to perturbed MT functions (39).
Considering that the degree of tyrosination modulates bending
ﬂexibility of MTs in muscles (40), it is conceivable that the ex-
pression of TUBA4A regulates the bending of MTs during platelet
formation.
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Figure 5. Abnormal ultrastructure of stage III bone
marrow MKs in Tuba4aV260E/V260E mice.
(A) Distribution of bone marrow MKs according to their
stage of differentiation (I–III). MKs were staged in wild-
type and Tuba4aV260E/V260E mice according to
morphological criteria (described in the Materials and
Methods section) from transmission electron
microscopy examination of bone marrow sections. Data
expressed as the percentage of each stage correspond
to 80 and 99 cells analyzed, respectively. Stage III*
corresponds to MKs with an abnormal ultrastructure as
represented in panel B. (**P < 0.001; two-way ANOVA
with Bonferroni posttest). (B) Representative
transmission electron microscopy images of stage III
MKs. A proportion of stage III MKs exhibited abnormal
ultrastructural features in Tuba4aV260E/V260E mice as
compared with wild-type mice, characterized by a
smaller size, a more condensed/compact demarcation
membrane system, and lack of peripheral zone.
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A comparison of Tuba4aV260E/V260E and Tubb1-KO mice revealed
striking similarities in platelet and MK defects. In both mouse
models, platelets showed round morphology and decreased
numbers of MT coils in marginal bands. The TUBA4A mutations in
the patient also had a strong impact on platelet size and mor-
phology but did not result in a lower number of MT coils. Similar
observations were also made in several patients with TUBB1 mu-
tations (38), thus conﬁrming the similarity of the defects caused by
dysfunctions of these two tubulin isotypes. As mechanisms con-
trolling the number of coils are still unknown, it is hard to predict
how the absence or reduction of α4A-tubulin could induce this
phenotype.
The increased size of platelets in both Tuba4aV260E/V260E (29.6%
diameter increase) and Tubb1-KO (+30.4% diameter increase; Fig S1)
suggests that both tubulin isotypes are essential to perform the
mechanical task of bending the MTs sufﬁciently to obtain the
correct platelet size and MT coil number. How α4A- and β1-tubulin
participate in this process could be different: β1-tubulin with its
highly divergent peptide sequence could directly change the
biophysical parameters of the MT lattice. α4A-tubulin, in contrast, is
highly similar to other α-tubulin isotypes; thus, the lack of the
C-terminal tyrosine might be essential for its function.
Mice and individuals defective in α4A- (this study) and β1-tubulin
(4, 5) similarly exhibit decreased platelet counts of moderate se-
verity, which varies depending on the particular mutation. They can
range from 45% in adult Tubb1-KO mice (Fig S1B) to subnormal
values in the patient reported here, and in some previously de-
scribed patients carrying TUBB1 mutations (38). Inefﬁcient pro-
platelet formation as shown in cultured MK from Tuba4aV260E/V260E,
Tubb1-KO, and TUBB1 patients could contribute to lower platelet
release into the circulation. Surprisingly though, the platelet counts
in blood are typically less affected as it could be expected from
the important defects in proplatelets observed in cultured MKs.
Indeed, discrepancies between effects observed in MK culture and
in vivo have been documented for other mouse models with
platelet defects (41). Although in vitro models might thus not fully
Figure 6. Impaired proplatelet formation in Tuba4aV260E/V260E mice.
(A) Proplatelet extensions in bone marrow explants. (left) Representative DIC microscopy images of MKs observed at the edge of a bone marrow slice showing well-
developed proplatelets in the wild-type and lack of pseudopodial extensions in Tuba4aV260E/V260E mice. (right) The graph represents the percentage of MKs displaying
proplatelets (wild type: 36.8 ± 8.1% and Tuba4aV260E/V260E: 2.1 ± 0.7%; N = 494 and 495 MKs, respectively; *P = 0.0112, t test). (B) Proplatelet extensions of MKs cultured from Lin−
progenitors. (left) Representative DIC microscopy images of MKs cultured for 4 d from Lin−progenitors showing MKs with abnormal shapes, displaying thick protrusions, in
Tuba4aV260E/V260E mice instead of well-developed proplatelets as seen in the WT. (right) The graph represents the percentage of MKs displaying proplatelets and thick
protrusions (WT: 44.3 ± 11.5% and 10.1 ± 1.1%, respectively; Tuba4aV260E/V260E: 29.3 ± 3.1% and 35.9 ± 2.1%, respectively; values from 213 WT and 162 Tuba4aV260E/V260EMKs). (**P <
0.001; two-way ANOVA with Bonferroni posttest).
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reproduce the in vivo situation, they can reveal subtle defects that
are not easily detected as pathologies in the ﬁrst place, but which
can become damaging in longer terms, that is, in ageing, or in
stress related to other pathologies. Altogether, similarities be-
tween mouse models and patients with β1- and α4A-tubulin
deﬁciencies strongly indicate that both isotypes are essential
for the correct formation of the marginal band during the ﬁnal
stages of MKmaturation. This implies that the isotype composition
of both, α- and β-tubulin pool, is essential for correct platelet
biogenesis.
We thus showed that macrothrombocytopenia is a common
salient feature of β1-tubulin (4, 5) and α4A-tubulin deﬁciencies.
Hereditary macrothrombocytopenia represent a group of rare
diseases for which a number of gene abnormalities have so far
been identiﬁed, including genes encoding transcription factors,
receptors and cytoskeletal proteins (42). However, genetic causes
for defects in platelet numbers and size still remain uncharac-
terized for approximately 50% of the patients (43). Considering that
this is the ﬁrst report of a TUBA4Amutation in a single patient, these
data will need independent validation from different patients to
more ﬁrmly link the mouse model to the human pathology. To this
end, genetic studies targeting this gene will be required to identify
additional cases of hereditary macrothrombocytopenia of yet
unknown origin caused by defects in TUBA4. How α4A- and β1-
tubulin control the structure and biophysical properties of MTs in
platelets remains to be determined. Considering that α4A-tubulin
affects the levels of tubulin detyrosination, our ﬁndings underpin
the importance of the tubulin code in the functional regulation of
MTs and emphasize the key role of this code for proper platelet
function.
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